Загрузка...
Target therapy in treatment of HER2-positive breast cancer
The breast cancer (BC) wins first place in structure of oncological incidence of the female population around the world. The special place is occupied by tumors with a superfluous expression of HER2 of a factor which is defined at 25–30 % of patients. Interest to suchpatients is defined by an aggres...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Russo |
| Опубликовано: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
| Серии: | Sibirskij Onkologičeskij Žurnal |
| Предметы: | |
| Online-ссылка: | https://www.siboncoj.ru/jour/article/view/103 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|